Last reviewed · How we verify

NCT03149328

Electronic Patient-Reported Outcomes in Clinical Kidney Practice (ePRO Kidney)

Completed NA Results posted Last updated 5 October 2021
What this trial tests

NA trial testing Educational Support in Kidney Disease, End-Stage in 594 participants. Completed in 31 October 2019.

Timeline
28 August 2017
Primary endpoint
31 October 2019
31 October 2019

Quick facts

Lead sponsorUniversity of Alberta
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment594
Start date28 August 2017
Primary completion31 October 2019
Estimated completion31 October 2019
Sites2 locations across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Alberta

Who can join

18 and older, any sex, with Kidney Disease, End-Stage. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Symptoms - Trajectory of Change Primary · Trajectories of up to 24 months from start of enrollment to study completion

Assessed using the symptoms/problems domain of the Kidney Disease Quality of Life 36-Item Short Form Survey (KDQOL-36). The Symptoms/Problems domain has 12 items, each representing a symptom or side effect of kidney disease based on the past 4 weeks with 5 response items ranging from "Not Bothered at all = 100" to "Extremely Bothered = 0". Min Score = 0; Max score = 100. Higher score indicates better health.

GroupValue95% CI
Clinician Support and Education Around Use of PROs in Home Dialysis Clinic77.2± 14.2
Usual Care76.2± 15.1
Person-centred Care - Trajectory of Change Primary · Trajectories of up to 24 months from start of enrollment to study completion

Assessed using the Patient Assessment of Care for Chronic Conditions (PACIC-20), a patient-reported experience measure on satisfaction with care over the past 6 months. The PACIC-20 is a 20-item survey based on five subscales: (1) patient activation, (2) delivery system design and decision support, (3) goal setting and tailoring, (4) problem-solving and contextual counselling, and (5) follow-up and coordination. Each item is rated on a five-point scale (from "Almost never = 0" to "Almost always = 5") and the subscale and total scores are based on average scores across items. Min score = 0; Max

GroupValue95% CI
Clinician Support and Education Around Use of PROs in Home Dialysis Clinic3.4± 1.1
Usual Care3.5± 1.0
Utilization of Health Services Secondary · From study enrollment until completion (up to 24 months)

Assessed using health services data (i.e. average number of hospital admissions, trips to the emergency room) determined through SPOR Platform and Alberta Health Services electronic health records. Higher numbers indicates worse outcomes.

Hospitalizations
GroupValue95% CI
Clinician Support and Education Around Use of PROs in Home Dialysis Clinic1.99± 2.15
Usual Care2.33± 2.52
Emergency Room Visits
GroupValue95% CI
Clinician Support and Education Around Use of PROs in Home Dialysis Clinic5.72± 7.28
Usual Care4.53± 5.58
Number of Participants Who Selected "1 - Excellent" on Satisfaction With Care Secondary · Up to 24 months from start of enrollment to study completion

Assessed using one item added to the end of the Patient Assessment of Care for Chronic Conditions 20 item questionnaire (PACIC-20) related to care received. This item is from the NHS Outpatient Survey (2011). (RateClin) related to care received on a Likert-type scale from Excellent = 1 to Very Poor = 6. Min = 1, max = 6. The number of patients who selected "1 - Excellent" was tabulated and compared between the two groups. The higher the number the more patients who felt the care provided to them was excellent.

GroupValue95% CI
Clinician Support and Education Around Use of PROs in Home Dialysis Clinic654
Usual Care547
Mental Health - Trajectory of Change Secondary · Trajectories of up to 24 months from start of enrollment to study completion

Assessed using the SF-12 mental component summary (MCS) subscale in the Kidney Disease Quality of Life 36-item Short-Form Survey (KDQOL-36). The SF-12 uses 2 items (psychological distress and psychological well being) to measure the MCS score. The summary score is transformed using Canadian norm-based scoring. The scores ranged from 0 (worst health) to 100 (best health). The higher the score the better the mental health.

GroupValue95% CI
Clinician Support and Education Around Use of PROs in Home Dialysis Clinic50.9± 8.4
Usual Care51.0± 8.3
Quality of Life - Trajectory of Change Secondary · Trajectories of up to 24 months from start of enrollment to study completion

Assessed using the Euro Quality of Life EQ-5D-5L. This assessment uses a descriptive system for health-related Quality of Life states in adults consisting of 5 dimensions; Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Each dimension is scored between 1 = indicating no problem and 5 = indicating unable to/extreme problems. An EQ-5D summary index is derived by applying a formula (the Canadian standard value set) that attaches values (weights) to each of the levels in each dimension. Index min= 0.0 max = 1.0. The higher the index the better the quality of life/st

GroupValue95% CI
Clinician Support and Education Around Use of PROs in Home Dialysis Clinic0.772± 0.182
Usual Care0.745± 0.196

Sponsor's own description

People living with end-stage kidney disease (ESKD) need dialysis or transplantation in order to stay alive. This illness and treatment significantly impact peoples' health, emotions, work and relationships. To promote person-centred care, healthcare professionals should be asking patients about what matters to them and using this feedback to plan and deliver care. Patient-reported outcome and experience questionnaires (jointly referred to as PROs) allow patients to provide information about their quality of life, symptoms and experiences with care. PROs are increasingly used to help healthcare professionals learn about what is important to patients and the impacts of illness or treatments from patients' point of view. Embedding feedback from patients into routine clinical practice is important in end-stage kidney disease because of the physical and quality of life challenges these patients face when living with kidney failure. PROs provide vital and often missing information that the healthcare team can use to support patients. However, PROs administered via paper questionnaires have been perceived as cumbersome, difficult to integrate with other health information and do not provide immediate feedback. In this research, home dialysis patients will have the opportunity to complete electronically administered PROs (ePROs) and healthcare professionals will receive education about how to use PRO information. The goal is to learn how to support healthcare professionals to routinely use this information to inform patient care, and see if this makes a difference in patients' symptoms, person-centred care, quality of life and satisfaction with care. Learning what matters most to patients is essential for healthcare professionals to provide person-centred care. This research will address the gap in our understanding of how to best use patients' reports in healthcare. Findings of this research may ultimately improve the quality of healthcare for Canadians living with end-stage kidney disease.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Electronic patient-reported outcomes in clinical kidney practice (ePRO Kidney): a process evaluation of educational support for clinicians.
    Schick-Makaroff K, Klarenbach S, Kwon JY, Cohen SR, et al · · 2023 · cited 7× · PMID 37332391 · DOI 10.1177/20406223231173624

Verify or expand the search:

Other trials of Educational Support

Trials testing the same drug.

Other recruiting trials for Kidney Disease, End-Stage

Currently open trials in the same condition.

Other University of Alberta trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03149328.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing